Medtronic (MEX:MDTN) Cyclically Adjusted Revenue per Share: MXN471.42 (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:MDTN Medtronic PLC MEX:MDTN
70 GF Score
Price MXN1,470.00
GF Value MXN1,708.74
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Medtronic Cyclically Adjusted Revenue per Share?

Medtronic MEX:MDTN 70 Cyclically Adjusted Revenue per Share is MXN471.42 as of Apr. 2026. GuruFocus rates MEX:MDTN with a GF Score™ of 70/100 and a GF Value™ of MXN1,708.74 (Modestly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Medtronic's adjusted revenue per share for the three months ended in Apr. 2026 was MXN133.391. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is MXN471.42 for the trailing ten years ended in Apr. 2026.

During the past 12 months, Medtronic's average Cyclically Adjusted Revenue Growth Rate was 4.70% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 4.20% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 6.30% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 6.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Medtronic was 17.40% per year. The lowest was 4.20% per year. And the median was 9.10% per year.

As of today (2026-07-20), Medtronic's current stock price is MXN1470.00. Medtronic's Cyclically Adjusted Revenue per Share for the quarter that ended in Apr. 2026 was MXN471.42. Medtronic's Cyclically Adjusted PS Ratio of today is 3.12.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Medtronic was 6.71. The lowest was 2.68. And the median was 4.81.


Medtronic  (MEX:MDTN) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Medtronic's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=1470.00/471.42
=3.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Medtronic was 6.71. The lowest was 2.68. And the median was 4.81.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Medtronic Cyclically Adjusted Revenue per Share Related Terms


Medtronic Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Medtronic's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medtronic Cyclically Adjusted Revenue per Share Chart

Medtronic Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25 Apr26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 470.33 377.19 438.75 523.35 471.42

Medtronic Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 523.35 490.34 509.93 454.17 471.42

MEX:MDTN vs SYK, BSX, EW: Cyclically Adjusted Revenue per Share Comparison

For the Medical Devices subindustry, Medtronic's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medtronic Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medtronic's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Medtronic's Cyclically Adjusted PS Ratio falls into.


MEX:MDTN
70GF Score
Medtronic PLC MEX:MDTN
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medtronic Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Medtronic's adjusted Revenue per Share data for the three months ended in Apr. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Apr. 2026 (Change)*Current CPI (Apr. 2026)
=133.391/128.4300*128.4300
=133.391

Current CPI (Apr. 2026) = 128.4300.

Medtronic Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201607 95.545 100.872 121.647
201610 99.111 99.776 127.574
201701 109.714 99.178 142.074
201704 108.492 100.773 138.268
201707 95.942 100.673 122.395
201710 98.740 100.374 126.340
201801 101.346 99.377 130.975
201804 111.906 100.374 143.186
201807 100.577 101.470 127.299
201810 111.344 101.271 141.205
201901 106.284 100.075 136.399
201904 114.487 102.068 144.056
201907 105.270 101.969 132.588
201910 109.335 101.969 137.708
202001 107.861 101.371 136.653
202004 106.552 101.969 134.203
202007 107.129 101.570 135.459
202010 120.330 100.474 153.812
202101 116.138 101.171 147.429
202104 121.617 103.065 151.548
202107 116.861 103.763 144.642
202110 118.987 105.557 144.770
202201 118.644 106.255 143.405
202204 122.542 110.242 142.760
202207 112.473 113.262 127.535
202210 113.023 115.315 125.877
202301 109.048 114.470 122.347
202304 115.324 118.213 125.291
202307 96.539 119.903 103.404
202310 108.218 121.111 114.758
202401 104.332 119.179 112.431
202404 110.732 121.232 117.307
202407 113.536 122.560 118.974
202410 130.798 121.956 137.741
202501 132.993 121.473 140.610
202504 135.807 123.888 140.786
202507 125.274 124.613 129.112
202510 129.034 125.410 132.141
202601 121.317 124.690 124.956
202604 133.391 128.430 133.391

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of MXN471.42 mean?
Medtronic (MEX:MDTN) has a Cyclically Adjusted Revenue per Share of MXN471.42 as of Apr. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Medtronic and its competitors.
Is Medtronic's Cyclically Adjusted Revenue per Share too high?
Medtronic's current Cyclically Adjusted Revenue per Share is MXN471.42. Overall, Medtronic has a GF Score™ of 70/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medtronic's Cyclically Adjusted Revenue per Share compare to SYK and BSX?
Medtronic's Cyclically Adjusted Revenue per Share of MXN471.42 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Medtronic and its competitors. Medtronic's current Cyclically Adjusted Revenue per Share is MXN471.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medtronic stock overvalued right now?
Based on GuruFocus' analysis, Medtronic (MEX:MDTN) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN1,708.74, compared to a current price of MXN1,470.00 — trading 14% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is MXN471.42. Medtronic's overall GF Score™ is 70/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Medtronic (MEX:MDTN), the current Cyclically Adjusted Revenue per Share is MXN471.42 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medtronic (MEX:MDTN) Overvalued in 2026?

Based on GuruFocus' analysis, Medtronic stock appears to be undervalued. The current stock price of MXN1,470.00 is trading 14% below its estimated GF Value™ of MXN1,708.74. GuruFocus considers Medtronic to be Modestly Undervalued.

Key valuation signals for MEX:MDTN:

  • Cyclically Adjusted Revenue per Share: MXN471.42
  • GF Value™: MXN1,708.74 vs. price of MXN1,470.00 (14% below fair value)
  • GF Score™: 70/100 with 3 warning signs

No single metric tells the full story. See the MEX:MDTN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medtronic Business Description

Address Parkmore Business Park West, Building Two, Galway, IRL
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
70GF Score

Get the complete analysis for MEX:MDTN

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,470.00
Price
MXN1,708.74
GF Value